Indivior (LON:INDV) Trading Up 9.9% - Time to Buy?

Indivior PLC (LON:INDV - Get Free Report) shares were up 9.9% on Monday . The company traded as high as GBX 1,090 ($14.88) and last traded at GBX 1,084 ($14.80). Approximately 496,685 shares were traded during mid-day trading, a decline of 39% from the average daily volume of 808,406 shares. The stock had previously closed at GBX 986 ($13.46).

Indivior Stock Performance

The firm has a market cap of £1.77 billion, a P/E ratio of -936.93, a PEG ratio of -5.57 and a beta of 0.19. The company has a current ratio of 0.83, a quick ratio of 1.52 and a debt-to-equity ratio of -170.06. The company's 50-day moving average is GBX 938.24 and its two-hundred day moving average is GBX 862.35.

Insider Buying and Selling

In related news, insider Juliet Thompson acquired 1,925 shares of the stock in a transaction dated Wednesday, June 11th. The stock was purchased at an average cost of GBX 1,388 ($18.95) per share, with a total value of £26,719 ($36,476.45). Corporate insiders own 3.44% of the company's stock.

About Indivior

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.